Health-related quality of life (HRQoL) in patients with hidradenitis suppurativa: a single center analysis
Introduction: Hidradenitis suppurativa (HS) is an underdiagnosed and undertreated skin affection. Previous studies suggest that psychiatric conditions are more frequent in patients with HS than in other dermotologic diseases. In Colombia, we found no descriptive studies of its comorbidities. We desc...
- Autores:
-
Castillo Molina, David
Chacón Jaramillo, Paula A.
Duran-Torres, Marcela
Fierro Lozada, Jesus Daniel
Molina Dorado, Daniela M.
Polania Tovar, Maria Daniela
Carroll Patiño , María Juliana
Vargas Caycedo, Zamira P.
ALVIS-ZAKZUK, NELSON J.
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2021
- Institución:
- Corporación Universidad de la Costa
- Repositorio:
- REDICUC - Repositorio CUC
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.cuc.edu.co:11323/9308
- Acceso en línea:
- https://hdl.handle.net/11323/9308
https://doi.org/10.1016/j.jaad.2021.06.144
https://repositorio.cuc.edu.co/
- Palabra clave:
- Hidradenitis suppurativa
Dermotologic diseases
Comorbidities
Psychiatric patients
- Rights
- openAccess
- License
- © 2021 Published by Elsevier Inc.
Summary: | Introduction: Hidradenitis suppurativa (HS) is an underdiagnosed and undertreated skin affection. Previous studies suggest that psychiatric conditions are more frequent in patients with HS than in other dermotologic diseases. In Colombia, we found no descriptive studies of its comorbidities. We described the HRQoL in patients with HS and its relationship with some comorbidities. Materials and Methods: We performed a descriptive and retrospective study in patients with HS in a dermotologic center in Bogotá, DC. We analyzed 24 patients attended from January 2017 to August 2020, assessing variables as age, sex, body mass index (BMI), and comorbidities. The dermatology life quality index (DLQI) and Hospital Anxiety and Depression scale (HAD) were applied in 19 patients. Univariate analysis and nonparametric statistics were performed. Data was collected and analyzed in Microsoft Excel 365 and SPSS26. Results: Of 24 patients, 18 were women (75%). The median age was 30 years old (IQR 21). The most frequently found comorbidities were acne and cardiovascular disease, 35.5% and 20.8%, respectively. DLQI’s most frequent result was a very large effect in 26.3% (n = 5). HADS-A showed anxiety in 6 cases (31.6%). HAD-D showed depression in 2 patients (10.5%). Conclusion: We found a greater association with acne and cardiovascular disease, which suggests a systemic and inflammatory involvement of the disease. Our findings related to HADS-A and DLQI reveal a great impact on the HRQoL and existence of anxiety symptoms, reinforcing the importance of multidisciplinary management. Further, larger studies are needed to validate these findings. |
---|